Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosome engineering: prospects for gene therapy.

B R Grimes1, P E Warburton, C J Farr

  • 1Department of Genetics, School of Medicine, Case Western Reserve University and University Hospital of Cleveland, Cleveland, OH 44106, USA.

Gene Therapy
|May 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data.

ESMO open·2026
Same author

Esperanto for histones: CENP-A, not CenH3, is the centromeric histone H3 variant.

Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2013
Same author

Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.

Oncogene·2011
Same author

Pulsed-field and two-dimensional gel electrophoresis of long arrays of tandemly repeated DNA : analysis of human centromeric alpha satellite.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Interstitial deletion of proximal 8q including part of the centromere from unbalanced segregation of a paternal deletion/marker karyotype with neocentromere formation at 8p22.

Cytogenetic and genome research·2011
Same author

A neocentromere derived from a supernumerary marker deleted from the long arm of chromosome 6.

Cytogenetic and genome research·2007

Researchers are advancing human artificial chromosome (HAC) technology for gene therapy. Progress in centromere function and construction methods offers an optimistic outlook for stable gene expression and therapeutic applications.

Area of Science:

  • Genetics
  • Molecular Biology
  • Gene Therapy

Background:

  • The development of human artificial chromosomes (HACs) is crucial for gene therapy.
  • Ensuring mitotic stability of HACs through functional centromeres remains a key challenge.

Purpose of the Study:

  • To present recent advances in HAC construction and their potential for gene therapy.
  • To discuss the structure and function of human centromeres in the context of HACs.

Main Methods:

  • 'Bottom up' construction: Transfer of circular PACs with alpha satellite DNA into HT1080 cells.
  • 'Top down' construction: Telomere-associated chromosome fragmentation in DT40 cells to create small HACs.
  • Utilizing HACs for gene correction (HPRT deficiency) and stable transgene expression.

Related Experiment Videos

Main Results:

  • Demonstrated successful transfer and mitotic stability of HACs in cell lines.
  • Created HACs smaller than one megabase and achieved germline transmission in mice.
  • Showcased stable transgene expression using human minichromosomes.

Conclusions:

  • Significant progress has been made in HAC engineering for gene therapy applications.
  • While challenges persist, the outlook for HAC-based gene therapy is optimistic.